Skip to content 
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified. more
| Time Frame | ARKG | S&P500 |
|---|---|---|
| 1-Week Return | -5.16% | 0.01% |
| 1-Month Return | 25.78% | 3.54% |
| 3-Month Return | 54.87% | 10.58% |
| 6-Month Return | 29.94% | 8.03% |
| 1-Year Return | 58.16% | 20.06% |
| 3-Year Return | 18.5% | 70.98% |
| 5-Year Return | -53.31% | 71.89% |
| 10-Year Return | 130.48% | 252.66% |
| Stock name | Ticker | Weight |
|---|---|---|
 TEMPUS AI INC-CL A | TEM | 7.96% |
 10X GENOMICS INC-CLASS A | TXG | 7.72% |
 TWIST BIOSCIENCE CORP | TWST | 7.39% |
 CRISPR THERAPEUTICS AG | CRSP | 6.65% |
 ABSCI CORP | ABSI | 6.59% |
 PERSONALIS INC | PSNL | 6.42% |
 BEAM THERAPEUTICS INC | BEAM | 4.45% |
 GUARDANT HEALTH INC | GH | 4.33% |
 ELI LILLY & CO | LLY | 4.29% |
 ILLUMINA INC | ILMN | 4.04% |
 NATERA INC | NTRA | 3.92% |
 VERACYTE INC | VCYT | 2.94% |
 RECURSION PHARMACEUTICALS-A | RXRX | 2.94% |
 CAREDX INC | CDNA | 2.82% |
 COMPASS PATHWAYS PLC | CMPS | 2.76% |
 INTELLIA THERAPEUTICS INC | NTLA | 2.61% |
 NURIX THERAPEUTICS INC | NRIX | 2.4% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 2.24% |
 BUTTERFLY NETWORK INC | BFLY | 2.22% |
 SCHRODINGER INC | SDGR | 1.99% |
 GENEDX HOLDINGS CORP | WGS | 1.8% |
 IONIS PHARMACEUTICALS INC | IONS | 1.44% |
 PRIME MEDICINE INC | PRME | 1.36% |
 ATAIBECKLEY INC | ATAI | 1.32% |
 CERUS CORP | CERS | 1.32% |
 ALAMAR BIOSCIENCES INC | ALMR | 1.29% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 1.14% |
 GENERATE BIOMEDICINES INC | GENB | 1.08% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.99% |
 908 DEVICES INC | MASS | 0.9% |
 QUANTUM-SI INC | QSI | 0.38% |
 GOLDMAN FS TRSY OBLIG INST 468 | GOLDMAN.FS.TRSY.OBLIG.INST.468 | 0.32% |
 BIONTECH SE-ADR | BNTX | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ARK Genomic Revolution ETF (ARKG) share price today is $41.32.
Yes, Indians can buy shares of ARK Genomic Revolution ETF (ARKG) on Vested. To buy ARKG from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ARK Genomic Revolution ETF (ARKG) on Vested. You can start investing in ARK Genomic Revolution ETF (ARKG) with a minimum investment of $1.
The 52-week high price of ARK Genomic Revolution ETF (ARKG) is $44.47. The 52-week low price of ARK Genomic Revolution ETF (ARKG) is $22.73.
The stock symbol (or ticker) of ARK Genomic Revolution ETF is ARKG.
Yes, you can setup SIP in ARK Genomic Revolution ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of ARKG on the Vested app.
The expense ratio of ARK Genomic Revolution ETF (ARKG) is 0.75%.
Link copied 
